Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Intramural Hematoma clinical trials

3 of 4 indexed Intramural Hematoma trials are currently recruiting.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Intramural Hematoma: 4 US clinical trials tracked, 3 recruiting.

Intramural Hematoma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Rodney A. White, M.D., running 2 of these trials.

Enrollment posture brief

Registry condition intramural-hematoma

OPEN 3 | RECR 75% | LATE 0 | EARLY 0 | RANK #4115 | SPON 2

Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Intramural Hematoma (this)75%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Intramural Hematoma

Intramural Hematoma lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intramural Hematoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intramural Hematoma is recruiting above its size-band peers.

    3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Intramural Hematoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Endoluminal treament of thoracic lesions Device
1 trials
NEXUS Aortic Stent Graft System Device
1 trials
Endovascular Device
1 trials
Endovascular repair with Valiant PS-IDE Stent Graft Device
1 trials

US sites by state

Facility locations filed on Intramural Hematoma trials. A trial with sites in several states counts in each.

California 4 trials
North Carolina 2 trials
Indiana 2 trials
New York 1 trials
Missouri 1 trials
Michigan 1 trials
Maryland 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intramural Hematoma page

4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intramural Hematoma condition card totals 4 registered trials; most-linked intervention Endoluminal treament of thoracic lesions; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.